Adage Capital Partners Gp, L.L.C. Acadia Pharmaceuticals Inc Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $41.4 Million - $59.7 Million	2,328,093 Added 190.05%	3,553,093 $85.1 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $20 Million - $25.6 Million	1,225,000 New	1,225,000 $23.1 Million
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $2 Million - $4.4 Million	-80,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $3.28 Million - $4.54 Million	80,000 New	80,000 $4.28 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.